Drug profile · INN
propantheline bromide
PROPANTHELINE BROMIDE
propantheline bromide (PROPANTHELINE BROMIDE) is a muscarinic acetylcholine receptor m3 antagonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — propantheline bromide
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
propantheline bromide (PROPANTHELINE BROMIDE) is a muscarinic acetylcholine receptor m3 antagonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Muscarinic acetylcholine receptor M3 antagonist
Primary target: Muscarinic acetylcholine receptor M1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is propantheline bromide?
propantheline bromide (PROPANTHELINE BROMIDE) is a muscarinic acetylcholine receptor m3 antagonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for propantheline bromide?
PROPANTHELINE BROMIDE is a marketed brand name for propantheline bromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of propantheline bromide?
propantheline bromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.